Anavex Life Sciences’ (AVXL) “Buy” Rating Reiterated at D. Boral Capital
D. Boral Capital reaffirmed their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a report published on Wednesday morning,Benzinga reports. D. Boral Capital currently has a $46.00 price target on the biotechnology company’s stock. Separately, HC Wainwright reiterated a “buy” rating and issued a $42.00 price target on shares of […]
D. Boral Capital reaffirmed their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a report published on Wednesday morning,Benzinga reports. D. Boral Capital currently has a $46.00 price target on the biotechnology company’s stock. Separately, HC Wainwright reiterated a “buy” rating and issued a $42.00 price target on shares of […]
